[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$rhhby](/topic/$rhhby)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rhhby/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rhhby/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -X%  
**6 Months**: XX% +4%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-10-21  
**1-Year Low**: XX% on 2025-08-02  

**Most Supportive Themes**
- **Positive Developments and Investments:** (40%) Roche is making significant investments and announcements, including expanding its manufacturing hub and building new facilities.
- **Positive Sentiment and Engagement:** (30%) The sentiment around $rhhby is up, with increased mentions and engagements across social networks.
- **Alnylam Partnership and Zilebesiran:** (20%) The partnership with Alnylam and the advancement of Zilebesiran into a Phase X cardiovascular outcomes trial is viewed positively.
  
**Most Critical Themes**
- **Potential Cancer Risk with GLP-1RA:** (10%)  Some posts discuss a potential link between long-term GLP-1RA use and increased cancer risk, particularly for women.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |